BIOMAT Database Logo BIOMAT Database Logo

Delta 1-Testololactone, a nonadrogenic augmentor and inhibitor of androgens. 1960

L J LERNER, and A BIANCHI, and A BORMAN

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000726 Androgen Antagonists Compounds which inhibit or antagonize the biosynthesis or actions of androgens. Androgen Antagonist,Antiandrogen,Antiandrogens,Anti-Androgen Effect,Anti-Androgen Effects,Antiandrogen Effect,Antiandrogen Effects,Antagonist, Androgen,Antagonists, Androgen,Anti Androgen Effect,Anti Androgen Effects,Effect, Anti-Androgen,Effect, Antiandrogen,Effects, Anti-Androgen,Effects, Antiandrogen
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D013738 Testolactone An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer. 1-Dehydrotestolactone,Teslac,delta(1)-Testolactone,1 Dehydrotestolactone

Related Publications

L J LERNER, and A BIANCHI, and A BORMAN
delta 1-testololactone: clinical trials'.
August 1982, Cancer research,
L J LERNER, and A BIANCHI, and A BORMAN
Metabolism in vivo of delta 1-testololactone.
October 1961, The Journal of biological chemistry,
L J LERNER, and A BIANCHI, and A BORMAN
Enhancement of the hypertensinogenic action of 19-hydroxyandrostenedione by aromatase inhibitor, delta 1-testololactone.
December 1987, Endocrinology,
L J LERNER, and A BIANCHI, and A BORMAN
The metabolism of 4-14C-delta-1-testololactone.
April 1966, Steroids,
L J LERNER, and A BIANCHI, and A BORMAN
TREATMENT OF ADVANCED BREAST CARCINOMA WITH DELTA 1-TESTOLOLACTONE.
January 1964, Acta - Unio Internationalis Contra Cancrum,
L J LERNER, and A BIANCHI, and A BORMAN
In vivo effects of delta 1-testololactone on peripheral aromatization.
August 1982, Cancer research,
L J LERNER, and A BIANCHI, and A BORMAN
A dose response evaluation of delta-1-testololactone in advanced breast cancer.
January 1974, Cancer,
L J LERNER, and A BIANCHI, and A BORMAN
High-dosage delta-1-testololactone therapy of disseminated carcinoma of the breast.
March 1967, Cancer,
L J LERNER, and A BIANCHI, and A BORMAN
[Behavior of serum lactic dehydrogenase (LDH) in disseminated breast cancer treated with delta-1-testololactone].
December 1962, Gazzetta internazionale di medicina e chirurgia,
L J LERNER, and A BIANCHI, and A BORMAN
[THE HORMONAL TREATMENT OF ADVANCED BREAST CANCER. STUDY METHODS: COMPARISON OF DELTA-1-TESTOLOLACTONE WITH TESTOSTERONE PROPIONATE].
January 1963, Acta clinica Belgica,
Copied contents to your clipboard!